scholarly journals Characterization, Purification of Poncirin from Edible Citrus Ougan (Citrus reticulate cv. Suavissima) and Its Growth Inhibitory Effect on Human Gastric Cancer Cells SGC-7901

2013 ◽  
Vol 14 (5) ◽  
pp. 8684-8697 ◽  
Author(s):  
Xiaoyan Zhu ◽  
Fenglei Luo ◽  
Yixiong Zheng ◽  
Jiukai Zhang ◽  
Jianzhen Huang ◽  
...  
2013 ◽  
Vol 66 (2) ◽  
pp. 201-208 ◽  
Author(s):  
Ming Zhao ◽  
Qingqing Wang ◽  
Zhen Ouyang ◽  
Bangxing Han ◽  
Wenbing Wang ◽  
...  

Author(s):  
Seock-Ah Im ◽  
Ahrum Min ◽  
Hyung-Seok Hur ◽  
Young-Kwang Yoon ◽  
Sang Hyun Song ◽  
...  

2019 ◽  
Vol 10 (6) ◽  
Author(s):  
Wenjuan Zhou ◽  
Liying Ma ◽  
Jing Yang ◽  
Hui Qiao ◽  
Lingyu Li ◽  
...  

Abstract Human mutT homolog 1(MTH1), the oxidized dNTP pool sanitizer enzyme, has been reported to be highly expressed in various malignant tumors. However, the oncogenic role of MTH1 in gastric cancer remains to be determined. In the current study, we found that MTH1 was overexpressed in human gastric cancer tissues and cells. Using an in vitro MTH1 inhibitor screening system, the compounds available in our laboratory were screened and the small molecules containing 5-cyano-6-phenylpyrimidine structure were firstly found to show potently and specifically inhibitory effect on MTH1, especially compound MI-743 with IC50 = 91.44 ± 1.45 nM. Both molecular docking and target engagement experiments proved that MI-743 can directly bind to MTH1. Moreover, MI-743 could not only inhibit cell proliferation in up to 16 cancer cell lines, especially gastric cancer cells HGC-27 and MGC-803, but also significantly induce MTH1-related 8-oxo-dG accumulation and DNA damage. Furthermore, the growth of xenograft tumours derived by injection of MGC-803 cells in nude mice was also significantly inhibited by MI-743 treatment. Importantly, MTH1 knockdown by siRNA in those two gastric cancer cells exhibited the similar findings. Our findings indicate that MTH1 is highly expressed in human gastric cancer tissues and cell lines. Small molecule MI-743 with 5-cyano-6-phenylpyrimidine structure may serve as a novel lead compound targeting the overexpressed MTH1 for gastric cancer treatment.


2010 ◽  
Vol 29 (8) ◽  
pp. 752-760 ◽  
Author(s):  
Ye Zhao ◽  
Jian-Sheng Li ◽  
Ming-Zhou Guo ◽  
Bai-Sui Feng ◽  
Jin-Ping Zhang

2000 ◽  
Vol 118 (4) ◽  
pp. A553
Author(s):  
Kohichi Takada ◽  
Junji Kato ◽  
Rishu Takirnoto ◽  
Katsunori Sasaki ◽  
Takeshi Teruui ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document